Tech Company Financing Transactions
ProteinQure Funding Round
ProteinQure closed a $11 million Series A financing round on 5/28/2025. Backers included private investors, Golden Ventures and Kensington Capital Partners.
Transaction Overview
Company Name
Announced On
5/28/2025
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to support the initiation of its first clinical trial for PQ203, a first-in-class peptide-drug conjugate for triple-negative breast cancer (TNBC), and the advancement of additional pipeline programs in neurology and nephrology.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
119 Spadina Ave. 304
Toronto ON, M5V 2L1
Canada
Toronto ON, M5V 2L1
Canada
Phone
Website
Email Address
Overview
ProteinQure is a Toronto-based startup building a computational platform for design of protein therapeutics. Our mission is to help to create a world where drugs are engineered, not discovered.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lucas Siow
Chief Scientific Officer
Chris Ing
Chief Technical Officer
Tomas Babej
VP - Operations
Naman Agarwal
VP - R & D
Mark Fingerhuth
Browse more venture capital transactions:
Prev: 5/28/2025: Creatify venture capital transaction
Next: 5/28/2025: Minset venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs